The Global Lysosomal Storage Disease Treatment Market was valued at US$ 7,217.9 Mn in 2020 and is forecast to reach US$ 15,792.6 Mn by 2028 at a CAGR of 10% between 2022- 2028. Lysosomal storage disease (LSD) results from defects in lysosomal function and degradation pathways. It occurs due to the gradual accumulation of metabolites. LTD is a rare genetic metabolic […]
